
HIGHLIGHTS
EVENTS
World Hemophilia Day 2021, Kedrion alongside patients
Today, more than ever, the company is close to those who are in a vulnerable condition
read morePLASMA & BIOTHERAPIES
Rh&Life, first subject included in the study
Two hundred pregnant women to be enrolled over five countries
read morePLASMA & BIOTHERAPIES
KIDCARES10, first patient enrolled in pediatric PI study
Thirty patients aged 2 to 17 years old to be enrolled over five European countries
read more-
EVENTS - 15-04-2021
World Hemophilia Day 2021, Kedrion alongside patients
Today, more than ever, the company is close to those who are in a vulnerable condition
read more -
PLASMA & BIOTHERAPIES - 07-04-2021
Rh&Life, first subject included in the study
Two hundred pregnant women to be enrolled over five countries
read more -
PLASMA & BIOTHERAPIES - 02-04-2021
KIDCARES10, first patient enrolled in pediatric PI study
Thirty patients aged 2 to 17 years old to be enrolled over five European countries
read more -
PLASMA & BIOTHERAPIES - 01-04-2021
Updates on anti-COVID treatment developed by Kamada and Kedrion
Top-line results announced from the phase 1/2 clinical trial in Israel
read more
Pages
For more information please contact: [email protected]